openPR Logo
Press release

Eczema Treatment Market; Key Trends and Opportunities

01-08-2018 07:56 AM CET | Health & Medicine

Press release from: TMR - Research Report

/ PR Agency: TMR - Research Report

Eczema, also referred as dermatitis or atopic dermatitis, is a disease which results in inflammation of the skin. Eczema is characterized by rash, red skin, and itchiness. The area of the skin involved may vary from small to the entire body. Few combination of factors such as genetical factor, abnormal function of immune system, environmental factor, defects in skin barrier, and activities may cause the skin to be extremely sensitive. The types of dermatitis are determined by location of rash, severity, and the patient’s history. This skin condition is most common in children and affects adult population as well. The symptoms of eczema vary from person to person. Dry itchy red skin, skin rashes, bumpy rashes, and blisters are the most common symptoms of the skin disease. The eczema treatment primarily includes steroid creams and moisturizers. In some cases, antibiotics are required if there was skin infection. Diagnosis of eczema is mostly based on physical examination; in few cases, skin biopsy is performed. The eczema treatment aims to control symptoms by reducing inflammation and relieving itching. The treatment includes calcineurin inhibitors, systemic immunomodulators such as cyclosporine, and other options include antihistamines and vitamin derivatives. Recent improvements in the eczema treatment have increased the quality of life of many patients but still large affected population of about 66.3 million patients are left untapped.

Read Report Overview: https://www.transparencymarketresearch.com/eczema-treatment-market.html

The global eczema treatment market is expected to be driven by new product launches in the near future. The launch of Sanofi/Regeneron’s dupilumab is projected to be the first biological for the treatment of moderate-to-severe eczema. This launch is expected to play a major role in driving the growth of the global market. Another key driver of the market growth is estimated to be the continued use of topical calcineurin inhibitors and increased systemic therapies. The highly genericized nature of the eczema treatment is likely to deter the growth of the market.

The global eczema treatment market has been segmented based on type of treatment, distribution channel, and geography. On the basis of the type of treatment, the global eczema treatment market is segmented into corticosteroids, emollients/moisturizers, antihistamines, calcineurin inhibitors, antibiotics, immunomodulators, and interleukin inhibitors. The use of corticosteroid therapy is considered first line therapy for adult and pediatric patients. The topical calcineurin inhibitors include tacrolimus and pimecrolimus. The use of . As corticosteroids are first line agents, the segment is expected to contribute a major share compared to other class of drugs in the global eczema treatment market. Based on distribution channel, the global market has been categorized into hospital and retail pharmacies, drug stores, and online or mail pharmacies. Among the end-user segments, hospital and retail pharmacies are expected to contribute a significant market share.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20312

By geography, the global eczema treatment market is segmented into five key regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. According to the National Eczema Association, eczema affects 10% to 20% of children and 1% to 3% of adults in the U.S. every year. This high prevalence of the disease is expected to lead North America in the global eczema treatment market. The U.K., France, Germany, and Italy are expected to gain market share rapidly making Europe the second leading market for eczema treatment worldwide. India and China are the major countries accounting for a larger proportion of the total prevalent cases around the globe, driving the growth of the Asia Pacific market.

Key players operating in the global eczema treatment market are Sanofi, Astellas Pharma, Anacor Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Meda AB, GlaxoSmithKline, AstraZeneca, and Pfizer Inc.

Pre Book Eczema Treatment Market Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=20312<ype=S

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Eczema Treatment Market; Key Trends and Opportunities here

News-ID: 888724 • Views:

More Releases from TMR - Research Report

Global Tissue Extraction System Market: Trends and Opportunities 2017 - 2025
Global Tissue Extraction System Market: Trends and Opportunities 2017 - 2025
Global Tissue Extraction System Market: Overview The global tissue extraction system market is foretold to display an impressive growth rate in the coming years. This could be owing to the need for tissue extraction or biopsy for cancer analysis after the patient has been suspected of carrying the disease. The procedure is extremely vital for diagnosing the disease. Thus, increasing prevalence of carcinogenic agents, compromised immunity levels, and rising incidence of
Neurology Sterile Injectable Market: Growth Factors, Applications, Regional Analysis 2017 - 2025
Neurology Sterile Injectable Market: Growth Factors, Applications, Regional Anal …
Neurology sterile injectables are generally administered to individuals suffering from pain linked to the nerves. Neuropathic pain injections are used to provide relief to these individuals. Neurology sterile injectable block the pain signal from reaching the brain. Neurological sterile injection can be administered at sympathetic nervous system, trigger points, dorsal roots, and peripheral nerves. The most commonly use neurological injectable used for nerve block are steroid injection, opioids, and local
External Fixator Devices Market: Global Survey and Trend Research
External Fixator Devices Market: Global Survey and Trend Research
External fixator devices are used to stabilize and support long bone open fractures to help the patient carry body’s weight as well as movement. Schanz screws, connecting rods, and clamps are used in case of unipolar external fixators. Circulatory fixators include circular rings, wires, connecting rods, and struts. The external fixator devices provide rigid fixation along with fixed distraction of the fracture fragments. The major advantage of external fixator devices
Anorectal Preparations Market Trends, and Forecast 2017 - 2025
Anorectal Preparations Market Trends, and Forecast 2017 - 2025
Anorectal preparations are products that contain a combination of an anti-inflammatory agent, or a pain reliever, and a local anesthetic as a suppository, or an ointment. External or internal hemorrhoids are treated by the topical application of anorectal preparations. Hemorrhoids are masses or lumps of tissue in the anus that contain enlarged blood vessels. The formation of hemorrhoids is due to an increase in abdominal pressure. Frequent constipation, which is

All 5 Releases


More Releases for Eczema

Eczema Therapeutics Market Share Forecast 2027 | Research Informatic
"Eczema Therapeutics market" research report is an expert's analysis which mainly includes companies, types, applications, regions, countries, etc. Also, the reports give an analysis of sales, revenue, trade, competition, investment, and forecast. Eczema Therapeutics market research covers COVID-19 impacts on the upstream, midstream, and downstream industries. Also, this study offers detailed market estimates by emphasizing statistics on several aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news
Global Baby Eczema Cream Sales Market Report 2017
Global Baby Eczema Cream market competition by top manufacturers/players, with Baby Eczema Cream sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Eucerin Aveeno Babyganics Exederm Mustela Elizabeth Parker Cetaphil A-Derma Munuka Wild Naturals TruBaby Michaderm Weleda Tiny Troubles Get a PDF sample of this report @ http://www.qyresearchreports.com/sample/sample.php?rep_id=1308802&type=E Table of Contents Global Baby Eczema Cream Sales Market Report 2017 1 Baby Eczema Cream Market Overview 1.1 Product Overview and Scope of Baby Eczema Cream 1.2 Classification of Baby Eczema Cream by Product
Eczema Treatment Market During 2017 to 2025
Eczema, also referred as dermatitis or atopic dermatitis, is a disease which results in inflammation of the skin. Eczema is characterized by rash, red skin, and itchiness. The area of the skin involved may vary from small to the entire body. Few combination of factors such as genetical factor, abnormal function of immune system, environmental factor, defects in skin barrier, and activities may cause the skin to be extremely sensitive.
Eczema Treatment Market: Latest Trends & Insights 2025
Eczema, also referred as dermatitis or atopic dermatitis, is a disease which results in inflammation of the skin. Eczema is characterized by rash, red skin, and itchiness. The area of the skin involved may vary from small to the entire body. Few combination of factors such as genetical factor, abnormal function of immune system, environmental factor, defects in skin barrier, and activities may cause the skin to be extremely sensitive.
Eczema Treatment Market : Emerging Trends & Upcoming Pharmaceutical Research
Eczema, also referred as dermatitis or atopic dermatitis, is a disease which results in inflammation of the skin. Eczema is characterized by rash, red skin, and itchiness. The area of the skin involved may vary from small to the entire body. Few combination of factors such as genetical factor, abnormal function of immune system, environmental factor, defects in skin barrier, and activities may cause the skin to be extremely sensitive.
Baby Eczema: Symptoms and Treatments.
A skin disease named as eczema is very harmful to the people of any age groups. It becomes more difficult for the parents to handle if the eczema has affected a child. Generally, this skin disease occurs in the early childhood in the form dry and red skin. This is known as baby eczema that comes with severe itching. Baby eczema affects those children who have very low level of